BostonGene, developer of the leading AI model for tumor and immune biology, today announced that nine abstracts have been accepted at the 2026 ASCO Annual Meeting (ASCO), scheduled to take place May ...
The RNA profiling core provides access to expertise and infrastructure for advanced transcriptomic profiling approaches, including Ribosome Profiling (mapping of translating ribosomes), CLIP (mapping ...
Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior ...
Gustave Roussy partners with One Biosciences, a techbio company that harnesses single cell technology and AI to develop advanced precision diagnostics. The collaboration aims to further demonstrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results